XTX Topco Ltd Has $297,000 Stock Holdings in Integer Holdings Co. (NYSE:ITGR)

XTX Topco Ltd trimmed its position in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 66.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,239 shares of the medical equipment provider's stock after selling 4,525 shares during the period. XTX Topco Ltd's holdings in Integer were worth $297,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Loomis Sayles & Co. L P raised its position in Integer by 3.8% in the fourth quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider's stock valued at $74,041,000 after purchasing an additional 20,688 shares during the period. Congress Asset Management Co. raised its position in Integer by 2.0% in the fourth quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider's stock valued at $66,041,000 after purchasing an additional 9,565 shares during the period. Charles Schwab Investment Management Inc. raised its position in Integer by 1.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 408,588 shares of the medical equipment provider's stock valued at $54,146,000 after purchasing an additional 4,559 shares during the period. Lord Abbett & CO. LLC raised its position in Integer by 3.5% in the third quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider's stock valued at $37,716,000 after purchasing an additional 9,754 shares during the period. Finally, Tributary Capital Management LLC raised its position in Integer by 0.8% in the fourth quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider's stock valued at $38,103,000 after purchasing an additional 2,289 shares during the period. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Down 0.5 %

Shares of NYSE ITGR traded down $0.61 during mid-day trading on Wednesday, reaching $126.32. 846,548 shares of the company traded hands, compared to its average volume of 347,939. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The stock has a market cap of $4.41 billion, a PE ratio of 37.60, a price-to-earnings-growth ratio of 1.72 and a beta of 1.09. The company's fifty day moving average is $118.92 and its two-hundred day moving average is $130.18. Integer Holdings Co. has a fifty-two week low of $104.93 and a fifty-two week high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. The firm had revenue of $437.39 million for the quarter, compared to analyst estimates of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. The company's revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.14 EPS. On average, analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have commented on ITGR. KeyCorp cut their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Benchmark dropped their target price on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Truist Financial set a $150.00 target price on Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. StockNews.com lowered Integer from a "hold" rating to a "sell" rating in a research report on Friday, April 25th. Finally, Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $145.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.